Review highlights design strategies and clinical challenges of protein-based nanoparticles, indicating their versatile applications.
Key Points
Protein-based nanoparticles offer advantages like biocompatibility and biodegradable properties for drug delivery, making them promising alternatives in medicine.
In-depth analysis of recent studies reveals that design strategies such as surface modification and stimuli-responsive engineering can improve therapeutic outcomes.
Key challenges affecting clinical translation include stability and immunogenicity, which need to be addressed to enhance the applicability of protein nanoparticles.
Emerging technologies in gene editing and protein-based therapies may significantly facilitate the development of next-generation protein-based nanoparticle solutions.